TP53 and acute myeloid leukemia: Our transcriptional profiling results suggest that the effect of the mevalonate and Wnt pathways in mediating resistance of TP53-mutant AML cells to CAR T-cells are restricted to TP53-mutant AML and CAR T-cells attacking TP53-mutant AML cells, respectively.